This positive association of BCL6 with clinical outcome has also been observed in primary central nervous system lymphoma, follicular lymphoma, and DLBCL, possibly because BCL6 enhances chemotherapy responses. The gene discussed is BCL6; the disease is primary central nervous system lymphoma.